← FDA Drug Approvals (Drugs@FDA)
ELUXADOLINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2026-06-02
Drug application
- FDA Application #
ANDA213511- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ELUXADOLINE
- Generic name
- Eluxadoline
- Active ingredients
- ELUXADOLINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- AUROBINDO PHARMA
- First approval
- 2026-06-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown